Another day, another delay for Novo's Catalent acquisition as FTC imposes 'Second Request'
Another day, another delay for Novo's Catalent acquisition as FTC imposes 'Second Request' fkansteiner Fri, 05/03/2024 - 13:50
Another day, another delay for Novo's Catalent acquisition as FTC imposes 'Second Request' fkansteiner Fri, 05/03/2024 - 13:50
Leo Pharma prepares to come for the topical JAK market as Incyte's Opzelura cream launch cools off zbecker Fri, 05/03/2024 - 10:56
As rival Merck monopolizes BCG supply, ImmunityBio taps Serum Institute for new combo's manufacturing aliu Fri, 05/03/2024 - 10:29
GSK defends itself—again—after senator argues it withdrew popular asthma med to dodge price caps and Medicaid rebates fkansteiner Fri, 05/03/2024 - 09:54
Amgen's new Horizon products bolster top line despite continued Tepezza struggles kdunleavy Fri, 05/03/2024 - 07:16
Fierce Pharma Asia—Ono buys Deciphera for $2.4B; Novartis expands PeptiDream collab; WuXi Bio exits BIO 2024 aliu Thu, 05/02/2024 - 23:01